Dalteparin vs. vitamin K antagonist (VKA) for the prevention of recurrent venous thromboembolism (VTE) in cancer patients with renal insufficiency: A patient level pharmacoeconomic analysis in three European countries
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2016-10, Vol.27, p.vi356-vi356 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | vi356 |
|---|---|
| container_issue | |
| container_start_page | vi356 |
| container_title | Annals of oncology |
| container_volume | 27 |
| creator | Shane, L. Dranitsaris, G. Woodruff, S. Galanaud, J.-P. Stemer, G. Debourdeau, P. Valtier, B. Burgers, L. |
| description | |
| doi_str_mv | 10.1093/annonc/mdw377.20 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdw377_20</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419446668</els_id><sourcerecordid>S0923753419446668</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2740-37c143e16ff513467023f5aa1092737cb98d07d097b1954f34b222ec891c9d993</originalsourceid><addsrcrecordid>eNp1UU1PGzEUtCoqNVDuHH0shw3-2I1jbhGkBYHEhfa6crzPxGjXXtneoPxU_g0PUo4cLH_MzJvnN4SccTbnTMsLE0IM9mLoXqRSc8G-kRlvFrpaspofkRnTQlaqkfUPcpzzM2NsoYWekddr0xcYTfKB7vKc7nwxA57vqAnFPMXgc6G__t2tzqmLiZYt0DHBDkLxMdDoaAI7pYR3io9xykhJcdhEwNX7PKD4cX1OsaQ1wUKioyke6Zm--LJFeTA9onlyzlsE7P6Srj5JtEerno5bkwZjI9gY4uAt9mb6ffb5vSz6AdD1lOIIBl3iFErykH-S7870GU7_7yfk7-_149VNdf_w5_ZqdV9ZoWpWSWV5LYEvnGu4rBeKCekaY3CoQiG40cuOqY5pteG6qZ2sN0IIsEvNre60lieEHeraFHNO4Nox-cGkfctZ-x5Ne4imPUTTCoaSy4MEsK-dh9Tmj69D53Gcpe2i_1r8BokEniY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Dalteparin vs. vitamin K antagonist (VKA) for the prevention of recurrent venous thromboembolism (VTE) in cancer patients with renal insufficiency: A patient level pharmacoeconomic analysis in three European countries</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Shane, L. ; Dranitsaris, G. ; Woodruff, S. ; Galanaud, J.-P. ; Stemer, G. ; Debourdeau, P. ; Valtier, B. ; Burgers, L.</creator><creatorcontrib>Shane, L. ; Dranitsaris, G. ; Woodruff, S. ; Galanaud, J.-P. ; Stemer, G. ; Debourdeau, P. ; Valtier, B. ; Burgers, L.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdw377.20</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2016-10, Vol.27, p.vi356-vi356</ispartof><rights>2016 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Shane, L.</creatorcontrib><creatorcontrib>Dranitsaris, G.</creatorcontrib><creatorcontrib>Woodruff, S.</creatorcontrib><creatorcontrib>Galanaud, J.-P.</creatorcontrib><creatorcontrib>Stemer, G.</creatorcontrib><creatorcontrib>Debourdeau, P.</creatorcontrib><creatorcontrib>Valtier, B.</creatorcontrib><creatorcontrib>Burgers, L.</creatorcontrib><title>Dalteparin vs. vitamin K antagonist (VKA) for the prevention of recurrent venous thromboembolism (VTE) in cancer patients with renal insufficiency: A patient level pharmacoeconomic analysis in three European countries</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1UU1PGzEUtCoqNVDuHH0shw3-2I1jbhGkBYHEhfa6crzPxGjXXtneoPxU_g0PUo4cLH_MzJvnN4SccTbnTMsLE0IM9mLoXqRSc8G-kRlvFrpaspofkRnTQlaqkfUPcpzzM2NsoYWekddr0xcYTfKB7vKc7nwxA57vqAnFPMXgc6G__t2tzqmLiZYt0DHBDkLxMdDoaAI7pYR3io9xykhJcdhEwNX7PKD4cX1OsaQ1wUKioyke6Zm--LJFeTA9onlyzlsE7P6Srj5JtEerno5bkwZjI9gY4uAt9mb6ffb5vSz6AdD1lOIIBl3iFErykH-S7870GU7_7yfk7-_149VNdf_w5_ZqdV9ZoWpWSWV5LYEvnGu4rBeKCekaY3CoQiG40cuOqY5pteG6qZ2sN0IIsEvNre60lieEHeraFHNO4Nox-cGkfctZ-x5Ne4imPUTTCoaSy4MEsK-dh9Tmj69D53Gcpe2i_1r8BokEniY</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Shane, L.</creator><creator>Dranitsaris, G.</creator><creator>Woodruff, S.</creator><creator>Galanaud, J.-P.</creator><creator>Stemer, G.</creator><creator>Debourdeau, P.</creator><creator>Valtier, B.</creator><creator>Burgers, L.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20161001</creationdate><title>Dalteparin vs. vitamin K antagonist (VKA) for the prevention of recurrent venous thromboembolism (VTE) in cancer patients with renal insufficiency: A patient level pharmacoeconomic analysis in three European countries</title><author>Shane, L. ; Dranitsaris, G. ; Woodruff, S. ; Galanaud, J.-P. ; Stemer, G. ; Debourdeau, P. ; Valtier, B. ; Burgers, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2740-37c143e16ff513467023f5aa1092737cb98d07d097b1954f34b222ec891c9d993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shane, L.</creatorcontrib><creatorcontrib>Dranitsaris, G.</creatorcontrib><creatorcontrib>Woodruff, S.</creatorcontrib><creatorcontrib>Galanaud, J.-P.</creatorcontrib><creatorcontrib>Stemer, G.</creatorcontrib><creatorcontrib>Debourdeau, P.</creatorcontrib><creatorcontrib>Valtier, B.</creatorcontrib><creatorcontrib>Burgers, L.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shane, L.</au><au>Dranitsaris, G.</au><au>Woodruff, S.</au><au>Galanaud, J.-P.</au><au>Stemer, G.</au><au>Debourdeau, P.</au><au>Valtier, B.</au><au>Burgers, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dalteparin vs. vitamin K antagonist (VKA) for the prevention of recurrent venous thromboembolism (VTE) in cancer patients with renal insufficiency: A patient level pharmacoeconomic analysis in three European countries</atitle><jtitle>Annals of oncology</jtitle><date>2016-10-01</date><risdate>2016</risdate><volume>27</volume><spage>vi356</spage><epage>vi356</epage><pages>vi356-vi356</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdw377.20</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2016-10, Vol.27, p.vi356-vi356 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdw377_20 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Dalteparin vs. vitamin K antagonist (VKA) for the prevention of recurrent venous thromboembolism (VTE) in cancer patients with renal insufficiency: A patient level pharmacoeconomic analysis in three European countries |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T06%3A58%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dalteparin%20vs.%20vitamin%20K%20antagonist%20(VKA)%20for%20the%20prevention%20of%20recurrent%20venous%20thromboembolism%20(VTE)%20in%20cancer%20patients%20with%20renal%20insufficiency:%20A%20patient%20level%20pharmacoeconomic%20analysis%20in%20three%20European%20countries&rft.jtitle=Annals%20of%20oncology&rft.au=Shane,%20L.&rft.date=2016-10-01&rft.volume=27&rft.spage=vi356&rft.epage=vi356&rft.pages=vi356-vi356&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdw377.20&rft_dat=%3Celsevier_cross%3ES0923753419446668%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753419446668&rfr_iscdi=true |